Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2017 | Pages:
191 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Post-Operative Pain - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H2 2017, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 10, 16, 8, 14, 3 and 2 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules, respectively. Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System). - The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System) Reasons to buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Post-Operative Pain - Overview 8 Post-Operative Pain - Therapeutics Development 9 Pipeline Overview 9 Pipeline by Companies 10 Pipeline by Universities/Institutes 14 Products under Development by Companies 15 Products under Development by Universities/Institutes 18 Post-Operative Pain - Therapeutics Assessment 19 Assessment by Target 19 Assessment by Mechanism of Action 22 Assessment by Route of Administration 25 Assessment by Molecule Type 27 Post-Operative Pain - Companies Involved in Therapeutics Development 29 Abide Therapeutics Inc 29 AcelRx Pharmaceuticals Inc 29 Adynxx Inc 30 AngioChem Inc 30 Aoxing Pharmaceutical Company Inc 31 Camurus AB 31 Cara Therapeutics Inc 32 Center Laboratories Inc 32 Colby Pharmaceutical Company 33 Cytogel Pharma LLC 33 Dompe Farmaceutici SpA 34 DURECT Corp 34 Eupraxia Pharmaceuticals Inc 35 EyeGate Pharmaceuticals Inc 35 Fujimoto Pharmaceutical Corp 36 GW Pharmaceuticals Plc 36 Heron Therapeutics Inc 37 Immupharma Plc 37 Innocoll AG 38 Insys Therapeutics Inc 38 Lipocure Ltd 39 Liquidia Technologies Inc 39 Medtronic Plc 40 Mundipharma International Ltd 40 Novartis AG 41 Orion Oyj 41 Pacira Pharmaceuticals Inc 42 PainReform Ltd 42 PhytoHealth Corp 43 PixarBio Corp 43 Proteus SA 44 Recro Pharma Inc 44 Relmada Therapeutics Inc 45 Serina Therapeutics Inc 45 SteadyMed Therapeutics Inc 46 Teikoku Pharma USA Inc 46 The Medicines Company 47 Trevena Inc 47 Xigen SA 48 Post-Operative Pain - Drug Profiles 49 (bupivacaine hydrochloride + meloxicam) ER - Drug Profile 49 (buprenorphine hydrochloride + granisetron hydrochloride) ER - Drug Profile 52 A-100 - Drug Profile 53 ABD-1970 - Drug Profile 54 ANG-2002 - Drug Profile 55 ARX-04 - Drug Profile 56 AYX-1 - Drug Profile 64 brimapitide - Drug Profile 67 bupivacaine hydrochloride - Drug Profile 71 bupivacaine hydrochloride - Drug Profile 72 bupivacaine hydrochloride - Drug Profile 73 bupivacaine hydrochloride - Drug Profile 74 bupivacaine hydrochloride SR - Drug Profile 77 bupivacaine hydrochloride SR - Drug Profile 82 buprenorphine hydrochloride - Drug Profile 83 CAM-2048 - Drug Profile 84 carbamazepine - Drug Profile 85 CPC-111 - Drug Profile 86 CPC-123 - Drug Profile 87 CT-044 - Drug Profile 88 Cyt-1010 - Drug Profile 89 dexamethasone acetate - Drug Profile 91 dexmedetomidine hydrochloride - Drug Profile 97 DF-2755A - Drug Profile 98 difelikefalin - Drug Profile 99 Drug to Agonize MOR1 for Pain - Drug Profile 109 ECP-1014 - Drug Profile 110 fadolmidine hydrochloride - Drug Profile 112 fentanyl - Drug Profile 113 gonyautoxin - Drug Profile 114 HTX-009 - Drug Profile 115 HYLP-002 - Drug Profile 116 IPP-102199 - Drug Profile 117 ketorolac tromethamine - Drug Profile 118 lacosamide - Drug Profile 119 levorphanol tartrate ER - Drug Profile 120 MDT-10013 - Drug Profile 122 meloxicam - Drug Profile 123 meloxicam ER - Drug Profile 128 MR-309 - Drug Profile 129 nabiximols - Drug Profile 131 nalbuphine hydrochloride - Drug Profile 138 neosaxitoxin - Drug Profile 139 oliceridine - Drug Profile 141 PMZ-2010 - Drug Profile 148 RBM-004 - Drug Profile 150 ropivacaine - Drug Profile 151 ropivacaine ER - Drug Profile 152 SAF-312 - Drug Profile 153 SER-226 - Drug Profile 154 Small Molecule for Post-Operative Pain - Drug Profile 155 Small Molecules to Inhibit COX for Postoperative Acute Pain - Drug Profile 156 sufentanil citrate - Drug Profile 157 tilidine hydrochloride - Drug Profile 165 tramadol hydrochloride - Drug Profile 166 URB-937 - Drug Profile 167 VVZ-149 - Drug Profile 168 XEN-105 - Drug Profile 170 Post-Operative Pain - Dormant Projects 171 Post-Operative Pain - Discontinued Products 174 Post-Operative Pain - Product Development Milestones 175 Featured News & Press Releases 175 Appendix 186 Methodology 186 Coverage 186 Secondary Research 186 Primary Research 186 Expert Panel Validation 186 Contact Us 186 Disclaimer 187
List of Tables
Number of Products under Development for Post-Operative Pain, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Companies, H2 2017 (Contd..2), H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Post-Operative Pain - Pipeline by Abide Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H2 2017 Post-Operative Pain - Pipeline by Adynxx Inc, H2 2017 Post-Operative Pain - Pipeline by AngioChem Inc, H2 2017 Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H2 2017 Post-Operative Pain - Pipeline by Camurus AB, H2 2017 Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by Center Laboratories Inc, H2 2017 Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H2 2017 Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H2 2017 Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H2 2017 Post-Operative Pain - Pipeline by DURECT Corp, H2 2017 Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H2 2017 Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H2 2017 Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H2 2017 Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H2 2017 Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by Immupharma Plc, H2 2017 Post-Operative Pain - Pipeline by Innocoll AG, H2 2017 Post-Operative Pain - Pipeline by Insys Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by Lipocure Ltd, H2 2017 Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H2 2017 Post-Operative Pain - Pipeline by Medtronic Plc, H2 2017 Post-Operative Pain - Pipeline by Mundipharma International Ltd, H2 2017 Post-Operative Pain - Pipeline by Novartis AG, H2 2017 Post-Operative Pain - Pipeline by Orion Oyj, H2 2017 Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H2 2017 Post-Operative Pain - Pipeline by PainReform Ltd, H2 2017 Post-Operative Pain - Pipeline by PhytoHealth Corp, H2 2017 Post-Operative Pain - Pipeline by PixarBio Corp, H2 2017 Post-Operative Pain - Pipeline by Proteus SA, H2 2017 Post-Operative Pain - Pipeline by Recro Pharma Inc, H2 2017 Post-Operative Pain - Pipeline by Relmada Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H2 2017 Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H2 2017 Post-Operative Pain - Pipeline by The Medicines Company, H2 2017 Post-Operative Pain - Pipeline by Trevena Inc, H2 2017 Post-Operative Pain - Pipeline by Xigen SA, H2 2017 Post-Operative Pain - Dormant Projects, H2 2017 Post-Operative Pain - Dormant Projects, H2 2017 (Contd..1), H2 2017 Post-Operative Pain - Dormant Projects, H2 2017 (Contd..2), H2 2017 Post-Operative Pain - Discontinued Products, H2 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
